Effects of IV Chloride Content on Outcomes

CompletedOBSERVATIONAL
Enrollment

1,558

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

April 1, 2014

Study Completion Date

April 1, 2014

Conditions
SIRSBalanced FluidsPlasmalyte
Trial Locations (1)

60015

Baxter Healthcare, Deerfield

All Listed Sponsors
lead

Baxter Healthcare Corporation

INDUSTRY

NCT02083198 - Effects of IV Chloride Content on Outcomes | Biotech Hunter | Biotech Hunter